Skip to Content
Merck
  • Peloruside- and laulimalide-resistant human ovarian carcinoma cells have ?I-tubulin mutations and altered expression of ?II- and ?III-tubulin isotypes.

Peloruside- and laulimalide-resistant human ovarian carcinoma cells have ?I-tubulin mutations and altered expression of ?II- and ?III-tubulin isotypes.

Molecular Cancer Therapeutics (2011)
Kanakkanthara A